140 related articles for article (PubMed ID: 16438895)
81. Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU)+/-folinic acid (FA) in a compassionate-use cohort of 370 5-FU-resistant advanced colorectal cancer (CRC) patients.
Bensmaïne ; de Gramont A; Brienza S; Marty M; Lévi F; Ducreux M; François E; Gamelin E; Bleiberg H; Bleuzen P; Simon J; Cvitkovic E
Eur J Cancer; 2000 Dec; 36(18):2335-43. PubMed ID: 11094307
[TBL] [Abstract][Full Text] [Related]
82. The efficacy of a modified chronomodulated infusion of oxaliplatin, 5-fluorouracil and leucovorin in advanced colorectal cancer (preliminary data).
Park JY; Kim SY; Lee JJ; Yoon HJ; Cho KS
Cancer Res Treat; 2004 Jun; 36(3):199-204. PubMed ID: 20396545
[TBL] [Abstract][Full Text] [Related]
83. Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study.
Celio L; Sternberg CN; Labianca R; La Torre I; Amoroso V; Barone C; Pinotti G; Cascinu S; Di Costanzo F; Cetto GL; Bajetta E
Ann Oncol; 2009 Jun; 20(6):1062-7. PubMed ID: 19218305
[TBL] [Abstract][Full Text] [Related]
84. [FOLFOX versus PLF regimen in treatment of advanced gastric adenocarcinoma].
Ye S; Rong J; Lin TY; Xiao J; Huang Y; Zhai LZ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1599-602. PubMed ID: 18819876
[TBL] [Abstract][Full Text] [Related]
85. Pharmacokinetics of oxaliplatin and non-hematological toxicity in metastatic gastrointestinal cancer patients treated with chronomodulated oxaliplatin, 5-FU and sodium folinate in a pilot investigation.
Merkel U; Farker K; Wedding U; Roskos M; Hippius M; Höffken K; Hoffmann A
Int J Clin Pharmacol Ther; 2006 Mar; 44(3):128-34. PubMed ID: 16550735
[TBL] [Abstract][Full Text] [Related]
86. Sequential moderate-dose methotrexate and 5-fluorouracil in advanced gastric adenocarcinoma.
Dickinson R; Presgrave P; Levi J; Milliken S; Woods R
Cancer Chemother Pharmacol; 1989; 24(1):67-8. PubMed ID: 2720894
[TBL] [Abstract][Full Text] [Related]
87. [Oxaliplatin in combination with calcium folinate and fluorouracil as neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
Fang Y; Wang YJ; Li F; Li J
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):510-2. PubMed ID: 17143797
[TBL] [Abstract][Full Text] [Related]
88. Is the combination of 5-fluorouracil and folinic acid effective in advanced gastric carcinoma? Results of a pilot study and review of the literature.
Pavlidis N; Nicolaides C; Klouvas G; Briassoulis E
J Chemother; 1994 Dec; 6(6):417-22. PubMed ID: 7699431
[TBL] [Abstract][Full Text] [Related]
89. Pharmaco-economic comparative evaluation of combination chronotherapy vs. standard chemotherapy for colorectal cancer.
Focan C
Chronobiol Int; 2002 Jan; 19(1):289-97. PubMed ID: 11962682
[TBL] [Abstract][Full Text] [Related]
90. Chronotherapy for cancer.
Eriguchi M; Levi F; Hisa T; Yanagie H; Nonaka Y; Takeda Y
Biomed Pharmacother; 2003 Oct; 57 Suppl 1():92s-95s. PubMed ID: 14572683
[TBL] [Abstract][Full Text] [Related]
91. Clinical pharmacokinetics of oxaliplatin in a hemodialysis patient with advanced gastric cancer.
Maruta M; Miyoshi T; Matsuo N; Yamashina T; Irie K; Tsuruta M; Tsukada H; Tsuruyama M; Nagano M; Hiraki Y
J Chemother; 2021 Feb; 33(1):51-55. PubMed ID: 32066346
[TBL] [Abstract][Full Text] [Related]
92. Chronomodulation of chemotherapy against metastatic colorectal cancer. International Organization for Cancer Chronotherapy.
Lévi F; Giacchetti S; Adam R; Zidani R; Metzger G; Misset JL
Eur J Cancer; 1995; 31A(7-8):1264-70. PubMed ID: 7577034
[TBL] [Abstract][Full Text] [Related]
93. Critical factors for optimizing the 5-fluorouracil-folinic acid association in cancer chemotherapy.
Etienne MC; Guillot T; Milano G
Ann Oncol; 1996 Mar; 7(3):283-9. PubMed ID: 8740793
[TBL] [Abstract][Full Text] [Related]
94. Etoposide, folinic acid, and 5-fluorouracil in carboplatin-pretreated patients with advanced gastric cancer.
Wilke H; Preusser P; Stahl M; Harstrick A; Meyer HJ; Achterrath W; Schmoll HJ; Seeber S
Cancer Chemother Pharmacol; 1991; 29(1):83-4. PubMed ID: 1742854
[TBL] [Abstract][Full Text] [Related]
95. High-dose folinic acid with 5-fluorouracil bolus and continuous infusion in the treatment of advanced gastric and oesophageal adenocarcinoma.
Highley MS; Hill ME; Ziras N; Samandas N; Mason RC; Owen W; Dussek J; Barker S; Harper PG
Br J Cancer; 1993 Feb; 67(2):407-8. PubMed ID: 8431376
[No Abstract] [Full Text] [Related]
96. Impact of the oxaliplatin-5 fluorouracil-folinic acid combination on respective intracellular determinants of drug activity.
Fischel JL; Formento P; Ciccolini J; Rostagno P; Etienne MC; Catalin J; Milano G
Br J Cancer; 2002 Apr; 86(7):1162-8. PubMed ID: 11953866
[TBL] [Abstract][Full Text] [Related]
97. Efficacy and safety of oxaliplatin, 5-Fluorouracil, and folinic Acid combination chemotherapy as first-line treatment in metastatic or recurrent gastric cancer.
Kim HJ; Eun JY; Jeon YW; Yun J; Kim KH; Kim SH; Kim HJ; Lee SC; Bae SB; Kim CK; Lee NS; Lee KT; Park SK; Won JH; Hong DS; Park HS
Cancer Res Treat; 2011 Sep; 43(3):154-9. PubMed ID: 22022292
[TBL] [Abstract][Full Text] [Related]
98. Oxaliplatin, 5-FU, folinic acid as first-line palliative chemotherapy in elderly patients with metastatic or recurrent gastric cancer.
Choi IS; Oh DY; Kim BS; Lee KW; Kim JH; Lee JS
Cancer Res Treat; 2007 Sep; 39(3):99-103. PubMed ID: 19746224
[TBL] [Abstract][Full Text] [Related]
99. [A Case of Advanced Gastric Cancer Presenting as Multiple Colonic Lymphoid Hyperplasia].
Lee IH; Lee JE; Byeon SW; Lee HJ; Huo SM; Yoon SB; Kim JS; Lee SH; Roh SY
Korean J Gastroenterol; 2015 Oct; 66(4):221-6. PubMed ID: 26493508
[TBL] [Abstract][Full Text] [Related]
100. Chemotherapy of advanced gastric cancer with 72-hour continuous intravenous 5-fluorouracil infusion at 2-week intervals.
Shah A; MacDonald WC
Med Pediatr Oncol; 1983; 11(5):358-60. PubMed ID: 6633428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
